Insights from a National Conference: “Conflicts of Interest in the Practice of Medicine”

Kesselheim A. S. , “Should FDA Drug and Medical Device Regulation Bar State Liability Claims?” Hearing before the House of Representatives Committee on Oversight and Government Reform (Rep. Waxman, Chairman), May 14, 2008, United States Congressional Record, H. HRG 110.

Kesselheim A. S. Maisel W. H. , “Conflict of Interest in Health Care Delivery: Protecting Patients' Interests,” American Journal of Therapeutics 17, no. 4 (2010): 440–443.

Horrobin D. F. , “Non-financial Conflicts of Interest Are More Serious Than Financial Conflicts,” BMJ 318, no. 7181 (1999): 466.

Kissick W. L. , Medicine's Dilemmas: Infinite Needs Versus Finite Resources (New Haven, CT: Yale University Press, 1994).

Falit B. P. Gross C. P. Roberts K. B. , “Integrated Prostate Cancer Centers and Over-Utilization of IMRT: A Close Look at Fee-for-Service Medicine in Radiation Oncology,” International Journal of Radiation Oncology*Biology*Physics 76, no. 5 (2010): 1285–1288.

Jacobson M. Earle C. C. Price M. Newhouse J. P. , “How Medicare's Payment Cuts for Cancer Chemotherapy Drugs Changed Patterns of Treatment,” Health Affairs 29, no. 7 (2010): 1391–1399.

Meier B. Thomas K. , “Some Doctors Cash In by Being Their Own Pharmacist,” New York Times, July 11, 2012, at A1.

Kowalczyk L. Allen S. , “AG Finds Clout of Hospitals Drives Cost,” Boston Globe, January 29, 2010, at A1.

Emanuel E. J. Pearson S. D. , “It Costs More, But Is It Worth More?” New York Times, January 3, 2012.

Lexchin J. Bero L. A. Djulbegovic B. Clark O. , “Pharmaceutical Industry Sponsorship and Research Outcome and Quality: Systematic Review,” BMJ 326, no. 7400 (2003): 1167–1170.

Ridker P. M. Torres J. , “Reported Outcomes in Major Cardiovascular Clinical Trials Funded by For-Profit and Not-For-Profit Organizations: 2000–2005,” JAMA 295, no. 19 (2006): 2270–2274.

Kesselheim A. S. , “Of-Label Drug Use and Promotion: Balancing Public Health Goals and Commercial Speech,” American Journal of Law and Medicine 37, nos. 2 & 3 (2011): 225–257.

Thompson D. F. , “Understanding Financial Conflicts of Interest,” New England Journal of Medicine 329, no. 8 (1993): 573–576.

Lessig L. , Republic, Lost: How Money Corrupts Congress – And a Plan to Stop It (New York, NY: Twelve, 2011).

Relman A. S. , “Medical Professionalism in a Commercialized Health Care Market,” JAMA 298, no. 22 (2007): 2668–2670.

Stossel T. P. Stell L. K. , “Time to ‘Walk the Walk’ about Industry Ties to Enhance Health,” Nature Medicine 17, no. 4 (2011): 437–438.

Lo B. , “The Future of Conflicts of Interest: A Call for Professional Standards,” Journal of Law, Medicine & Ethics 40, no. 3 (2012): 441–451.

Sage W. M. , “Some Principles Require Principals: Why Banning “Conflicts of Interest” Won't Solve Incentive Problems in Biomedical Research,” Texas Law Review 85, no. 6 (2007): 1413–1463.

Robertson C. Rose S. Kesselheim A. S. , “Effect of Financial Relationships on the Behaviors of Health Care Professionals: A Review of the Evidence,” Journal of Law, Medicine & Ethics 40, no. 3 (2012): 452–466.

Saver R. S. , “Is It Really All about the Money? Reconsidering Non-Financial Interests in Medical Research,” Journal of Law, Medicine & Ethics 40, no. 3 (2012): 467–481.

Kesselheim A. S. Lee J. L. Avorn J. Servi A. Shrank W. H. Choudhry N. K. , “Conflict of Interest in Oncology Publications,” Cancer 118, no. 1 (2012): 188–195.

Chimonas S. Patterson L. Raveis V. H. Rothman D. J. , “Managing Conflicts of Interest in Clinical Care: A National Survey of Policies at U.S. medical Schools,” Academic Medicine 86, no. 3 (2011): 293–299.

Steinbrook R. Ross J. S. , “‘Transparency Reports’” on Industry Payments to Physicians and Teaching Hospitals,” JAMA 307, no. 10 (2012): 1029–1030.

Sah S. , “Conflicts of Interest and Your Physician: Psychological Processes That Cause Unexpected Changes in Behavior,” Journal of Law, Medicine & Ethics 40, no. 3 (2012): 482–487.

Steinbrook R. Lo B. , “Medical Journals and Conflicts of Interest,” Journal of Law, Medicine & Ethics 40, no. 3 (2012): 488–499.

Greenwood K. Coleman C. Boozang K. , “Toward Evidence-Based Conflicts of Interest Training for Physician-Investigators,” Journal of Law, Medicine & Ethics 40, no. 3 (2012): 500–510.

See Lo, supra note 14.

Rodwin M. , “Conflicts of Interest, Institutional Corruption, and Pharma: An Agenda for Reform,” Journal of Law, Medicine & Ethics 40, no. 3 (2012): 511–522.